Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612508 · ClinicalTrials.gov registry record · NA
Hormonal Contraception and Vaginal Health
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00612508 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 14 participants.
The verdict
NCT00612508, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).
Interventions
- DRUG Desogen (ethinyl estradiol and desogestrel)
- DRUG NuvaRing (ethinyl estradiol and etonogestrel)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612508
The ClinicalTrials.gov registry entry for NCT00612508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Desogen (ethinyl estradiol and desogestrel) is the first listed.
NCT00612508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612508 about?
NCT00612508 is a clinical study titled "Hormonal Contraception and Vaginal Health". The purpose of this study is to help determine if the route by which women receive hormonal contraception causes different changes to occur in the lining of the vagina. The investigators plan to compare an oral route (taking birth control pills) with a vaginal route (using a vaginal ring).
What is the current status of trial NCT00612508?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2007-05. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00612508?
The interventions under investigation include: Desogen (ethinyl estradiol and desogestrel) (DRUG), NuvaRing (ethinyl estradiol and etonogestrel) (DRUG).
Who is sponsoring clinical trial NCT00612508?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.